Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
NCT07465432Phase 4Recruiting
- Sponsor
- University of Tennessee
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefiderocol in bacterial infection, sponsored by University of Tennessee. Started Feb 2026; status: recruiting.
02
Drugs
cefiderocol
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07465432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07465432.